Strategist Michael Antonelli joins Jared Blikre to break down the Fed decision and more at 2 P.M. ET Wednesday.
HONG KONG, June 21, 2022 /PRNewswire/ — Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a leading provider of deep biomarkers of aging and longevity is pleased to announce its collaboration with Dr. Nancy Etcoff of Harvard Medical School. Dr. Etcoff is widely recognized in the field of psychology and is a member of the Harvard University Mind/Brain/Behavior Initiative where she teaches a seminar on "The Science of Happiness." She is also a practicing psychologist at the Massachusetts General Hospital Department of Psychiatry where she is the director of the Program in Aesthetics and Well Being.
Today, Deep Longevity, in co-authorship with Dr. Etcoff, has published an article in Aging-US describing a machine learning approach to human psychology: "Optimizing future well-being with artificial intelligence: Self-organizing maps (SOMs) for the identification of islands of emotional stability." The article serves as the scientific background for a free self-help application, FuturSelf, developed by Deep Longevity.
The authors used data from the Midlife in the US study to create two digital models of human psychology.
The first model is an ensemble of deep neural networks that use information from a psychological survey to predict the chronological age of the respondents and their psychological well-being in 10 years. This model demonstrates the aging-related trajectories of the human mind. It also shows that the ability to build meaningful relationships increases with age, as do mental autonomy and environmental mastery. It simultaneously indicates that the focus on personal growth steadily declines, and the feeling of having a purpose in life only drops after 40–50 years. These findings contribute to the discussion of socioemotional selectivity and hedonic adaptation in the context of adult personality development.
The second model is a self-organizing map developed as the backbone of a recommendation engine for mental health applications. This automated learning technique divides all respondents into clusters based on their risk of developing depression and identifies the shortest path toward a cluster of mental stability for any individual. Alex Zhavoronkov, the Chief Longevity Officer of Deep Longevity, elaborates, "Existing mental health applications offer generic advice that applies to everyone yet fits no one. We have built a system that is scientifically sound and offers superior personalization."
To demonstrate this system's potential, Deep Longeivty has developed FuturSelf, a free online application that lets users take the psychological test described in the original publication. At the end of the assessment, users receive a report with insights aimed at improving their long-term mental health and well-being and can enrol in a guidance program that provides them with a steady flow of AI-chosen recommendations. Data obtained on FuturSelf will be used to further develop Deep Longevity's digital approach to mental health with the aim of offering the application via a B2B SaaS model to insurance companies, large corporates and other employers to allow their employees to track their own mental health and wellbeing.
In recent years, given the worldwide pandemic and its impact on workplace changes (including an increased emphasis on remote work and the associated psychological effects), large employers have developed a keen awareness of the importance of employee's mental health. In order to address how mental health can be tracked to help employees better cope with job demands and maximize their productivity, Deep Longevity is focused on providing highly scalable and commercial solutions that can be applied cost effectively across all industries. Using Deep Longevity's digital approach to managing mental health, an invaluable feedback loop is created that can help employees thrive by increasing their motivation and productivity or allowing them to seek important emotional support when required. On a per-employee basis, the cost to employers to provide this essential human resource function can be minimal. Ongoing discussions with large insurance companies and other multinational corporations suggest that the commercial opportunity for Deep Longevity (through Futurself and other applications) is immense and geographically scalable across all markets world-wide.
A leading biogerontology expert, professor Vadim Gladyshev from Harvard Medical School, comments on the potential of FuturSelf: "This study offers an interesting perspective on psychological age, future well-being, and risk of depression, and demonstrates a novel application of machine learning approaches to the issues of psychological health. It also broadens how we view aging and transitions through life stages and emotional states."
The authors plan to continue studying human psychology in the context of aging and long-term well-being. They are working on a follow-up study on the effect of happiness on physiological measures of aging.
Jamie Gibson, Chief Executive Officer of Endurance Longevity said, "As one of the forerunners in the longevity AI market, we are thrilled to achieve this remarkable milestone together with the world's top-notch scientists. We are confident about the future of integrating deep learning AI technologies in human psychology and the development of digital solution to improve people's mental health and overall well-being."
About Deep Longevity
Deep Longevity is a wholly owned subsidiary of Endurance Longevity (SEHK:0575.HK), a publicly-traded company. Deep Longevity is developing explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. It is also developing systems for the emerging field of longevity medicine, which enables physicians to make better decisions on the interventions that may slow down or reverse the aging processes. Deep Longevity developed Longevity as a Service (LaaS)© solution to integrate multiple deep biomarkers of aging dubbed "deep aging clocks" to provide a universal multifactorial measure of human biological age.
Originally incubated by Insilico Medicine, Deep Longevity started its independent journey in 2020 after securing a round of funding from the most credible venture capitalists specializing in biotechnology, longevity, and artificial intelligence: ETP Ventures; the Human Longevity and Performance Impact Venture Fund; BOLD Capital Partners; Longevity Vision Fund; LongeVC; Michael Antonov, the co-founder of Oculus; and other expert AI and biotechnology investors supported the company. Deep Longevity established a research partnership with one of the most prominent longevity organizations, Human Longevity, Inc., one of the most prominent longevity organizations to provide a range of aging clocks to the network of advanced physicians and researchers.
https://www.deeplongevity.com/
About Endurance Longevity (Stock code: 0575.HK)
Endurance Longevity is a diversified investment group based in Hong Kong currently holding various corporate and strategic investments focusing on the healthcare, wellness and life sciences sectors. The Group has a strong track record of investments and has returned approximately US$298 million to shareholders in the 21 years of financial reporting since its initial public offering.
www.endurancerp.com
This press release is distributed by LBS Communications Consulting Limited.
SOURCE Endurance RP Limited
Related Quotes
Shares in tobacco giant Altria Group Inc, which owns a 35% stake in Juul, were down 8% in morning trading after the report saying the agency's decision could arrive as early as Wednesday. The verdict would come around two years after the vaping products maker applied for approval to keep selling e-cigarettes in the country, trying to prove that the products offered a net benefit to public health. The FDA's review will decide whether they are effective in getting smokers to quit and, if so, whether the benefits to smokers outweigh the health damage to new users, including teenagers, who never smoked.
AbbVie (NYSE: ABBV) announced today that Health Canada has approved a change in the marketing authorization for MAVIRET® (glecaprevir/pibrentasvir) to include its use for the treatment in paediatric patients 3 to 12 years old, weighing at least 12kg to less than 45kg.1 MAVIRET is now approved as an 8-week, pan-genotypic (GT1-6) treatment for treatment-naïve, chronic HCV patients, without cirrhosis or with compensated cirrhosis in adults and children aged 3 years and older.1**
A partnership to open a new research and manufacturing centre in the UK will mean over £1 billion in mRNA research investment.
Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers including Pfizer and Moderna to cut or slow deliveries of about half a billion shots so doses are not wasted. COVAX, the World Health Organization-led scheme, wants between 400 and 600 million fewer vaccines doses than initially contracted from six pharmaceutical companies, according to internal documents seen by Reuters. While at first the initiative struggled for shots as wealthy nations snapped up limited supply, donations from those same countries later in 2021, as well as improved output from manufacturers – alongside delivery challenges and vaccine hesitancy in a number of countries – has led to a glut of vaccine in 2022.
U.S.-listed shares of AstraZeneca were up 2.5% in trading on Tuesday after the company said an experimental therapy for hereditary transthyretin-mediated amyloid polyneuropathy met its primary endpoints in a Phase 3 clinical trial. AstraZeneca is developing eplontersen with Ionis Pharmaceuticals Inc. ; shares in Ionis were up 5.1% on Tuesday. The rare disease can cause nerve damage and motor disability and affects about 40,000 people worldwide, the companies said. They also said they plan to see
Your blood type can reveal a lot about you like personality traits, but it can also indicate certain health issues you're at greater risk for such a cancer. Specific blood types have been associated with various cancers, however there are lifestyle choices you can make to help lower the risk according to experts. Read on to find out more—and to ensure your health and the health of others, don't miss Already Had COVID? These Symptoms May "Never Go Away". 1 Lung Cancer Dr. JB Kirby a doctorate-pre
As much as we all want the pandemic to be over, it's not. Cases are spiking in many areas and although safety precautions have been lifted, trying to avoid COVID is still recommended because there can be long lasting damaging effects that harm overall health and lingering symptoms that can continue for months. Eat This, Not That! Health spoke with different virus experts who explain what to know about COVID right now, when to still wear a mask and places to avoid in an effort to prevent getting
Krystal Biotech Inc. has applied to the U.S. Food and Drug Administration for permission for one of its gene therapies to treat a rare genetic skin disorder. Pittsburgh-based Krystal (Nasdaq: KRYS) said it had filed a biologics license application for beremagene geperpavec, also known as B-VEC, in the treatment of people with dystrophic epidermolysis bullosa (DEB). DEB is a skin disorder that often occurs at birth and involves blistering and scarring throughout the whole body and a potential for squamous cell carcinoma.
(Reuters) -The U.S. Supreme Court on Tuesday rejected dialysis provider DaVita Inc's claims that an Ohio hospital's employee health plan discriminates against patients with end-stage kidney disease by reimbursing them at low rates in hopes they would switch to Medicare. In a 7-2 decision https://fingfx.thomsonreuters.com/gfx/legaldocs/byvrjaqorve/06212022davita.pdf authored by conservative Justice Brett Kavanaugh, the court ruled that Marietta Memorial Hospital's employee health plan did not violate federal law by limiting benefits for outpatient dialysis because it did so without regard to whether patients had end-stage renal disease.
Hidradenitis suppurative is an inflammatory skin condition that can be localized throughout the body, specifically armpits, breasts and the groin.
Moderna said it would manufacture vaccines in the U.K. as part of a deal with the British government aimed at ensuring speedy access to mRNA vaccines in the event of future pandemics.
The government health-insurance program for seniors could have saved as much as $3.6 billion over one year if it had bought generic drugs from the pharmacy, Harvard Medical School researchers estimate.
From early in the pandemic, it quickly became clear that certain people would feel COVID-19′s wrath to a much higher degree than other people.
The Biden administration is writing a plan that would order cigarette manufacturers to cut nicotine levels.
COVID cases are again surging in Europe, driven by the BA.4 and BA.5 subvariants of omicron that are deemed to be 10% to 15% more infectious than earlier variants and are spreading fast in Portugal, France, Germany, Italy, Spain, Greece, the Netherlands and Denmark.
Experts share their advice about isolation, masking and more if you're still testing positive late into a COVID-19 infection.
Shares of Acadia Pharmaceuticals Inc. were still down 30.5% in premarket trading on Tuesday, days after a Food and Drug Administration advisory committee voted against approval of the company's treatment for hallucinations and delusions associated with Alzheimer's disease psychosis. The committee on Friday voted 9-3 that the benefits of pimavanserin do not outweigh the risks. The FDA, which is not required to follow the advice of the committee but often does, is expected to decide whether to app
Chinese scientists have reportedly developed and tested a device that aims to help online censors better police pornography in the country. Researchers at Beijing Jiaotong University in China created a helmet that can track the brain waves of its wearers. In China, where watching porn is illegal, the government employs mostly women as so-called porn appraisers, or “jian huang shi,” who screen online photo and video content.
The rule, expected in May 2023, would be designed with the goal of making it easier for tobacco users to quit and help prevent youth from becoming regular smokers, according to a document released by the White House Budget Office. Nicotine is the addictive substance in tobacco. Tobacco products also contain several harmful chemicals, many of which could cause cancer.
This “parade of planets” hasn’t been seen from Earth since 2004, and it won’t happen again until 2040.
